166 related articles for article (PubMed ID: 32297157)
1. Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients.
ElFihry R; Elmessaoudi-Idrissi M; Jadid FZ; Zaidane I; Chihab H; Tahiri M; Kabine M; Badre W; Chemin I; Marchio A; Pineau P; Ezzikouri S; Benjelloun S
Virol Sin; 2020 Oct; 35(5):566-574. PubMed ID: 32297157
[TBL] [Abstract][Full Text] [Related]
2. The peroxisome proliferator-activated receptor γ coactivator-1 alpha rs8192678 (Gly482Ser) variant and hepatitis B virus clearance.
Abounouh K; Tanouti IA; Ouladlahsen A; Tahiri M; Badre W; Dehbi H; Sarih M; Benjelloun S; Pineau P; Ezzikouri S
Infect Dis (Lond); 2023 Sep; 55(9):614-624. PubMed ID: 37376899
[TBL] [Abstract][Full Text] [Related]
3. Association of Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Alpha Coding Variants with Hepatocellular Carcinoma Risk in the Moroccan Population: A Case-Control Study.
Tanouti IA; Fellah H; El Fihry R; Zerrad C; Abounouh K; Tahiri M; Belkouchi A; Badre W; Pineau P; Benjelloun S; Ezzikouri S
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3689-3696. PubMed ID: 38019226
[TBL] [Abstract][Full Text] [Related]
4. A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children.
Lin YC; Chang PF; Chang MH; Ni YH
Am J Clin Nutr; 2013 Feb; 97(2):326-31. PubMed ID: 23269818
[TBL] [Abstract][Full Text] [Related]
5. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
[TBL] [Abstract][Full Text] [Related]
6. Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
Besse-Patin A; Léveillé M; Oropeza D; Nguyen BN; Prat A; Estall JL
Gastroenterology; 2017 Jan; 152(1):243-256. PubMed ID: 27658772
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
8. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
9. Assessment of
Chen Z; Wang Y; Wang J; Kang M; Tang W; Chen S
DNA Cell Biol; 2020 Sep; 39(9):1521-1531. PubMed ID: 32721231
[TBL] [Abstract][Full Text] [Related]
10. PPAR-alpha L162V polymorphism in human hepatocellular carcinoma.
Koytak ES; Mizrak D; Bektaş M; Verdi H; Arslan Ergül A; Idilman R; Cinar K; Yurdaydin C; Ersõz S; Karayalçin K; Uzunalimoğlu O; Bozkaya H
Turk J Gastroenterol; 2008 Dec; 19(4):245-9. PubMed ID: 19119483
[TBL] [Abstract][Full Text] [Related]
11. Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity.
Shores NJ; Mendes-Corrêa MC; Maida I; Turner J; High KP; Babudieri S; Núãez M
Clinics (Sao Paulo); 2015 Dec; 70(12):790-6. PubMed ID: 26735218
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinoma.
Liu R; Zhang H; Zhang Y; Li S; Wang X; Wang X; Wang C; Liu B; Zen K; Zhang CY; Zhang C; Ba Y
Tumour Biol; 2017 Apr; 39(4):1010428317695031. PubMed ID: 28381162
[TBL] [Abstract][Full Text] [Related]
13. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
[TBL] [Abstract][Full Text] [Related]
14. Association between PPARGC1A single nucleotide polymorphisms and increased risk of nonalcoholic fatty liver disease among Iranian patients with type 2 diabetes mellitus.
Saremi L; Lotfıpanah S; Mohammadi M; Hosseinzadeh H; Hosseini-Khah Z; Johari B; Saltanatpour Z
Turk J Med Sci; 2019 Aug; 49(4):1089-1094. PubMed ID: 31390852
[TBL] [Abstract][Full Text] [Related]
15. Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population.
Rebbani K; Ezzikouri S; Marchio A; Ababou M; Kitab B; Dejean A; Kandil M; Pineau P; Benjelloun S
Infect Genet Evol; 2014 Aug; 26():1-7. PubMed ID: 24797387
[TBL] [Abstract][Full Text] [Related]
16. Gene-environment interaction in chronic kidney disease among people with type 2 diabetes from The Malaysian Cohort project: a case-control study.
Ahmad N; Shah SA; Abdul Gafor AH; Abdul Murad NA; Kamaruddin MA; Abd Jalal N; Ismail N; Alias MR; Jamal R
Diabet Med; 2020 Nov; 37(11):1890-1901. PubMed ID: 32012348
[TBL] [Abstract][Full Text] [Related]
17. Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).
Yoneda M; Hotta K; Nozaki Y; Endo H; Uchiyama T; Mawatari H; Iida H; Kato S; Hosono K; Fujita K; Yoneda K; Takahashi H; Kirikoshi H; Kobayashi N; Inamori M; Abe Y; Kubota K; Saito S; Maeyama S; Wada K; Nakajima A
BMC Gastroenterol; 2008 Jun; 8():27. PubMed ID: 18588668
[TBL] [Abstract][Full Text] [Related]
18. The Role of Peroxisome Proliferator-Activated Receptors and Their Transcriptional Coactivators Gene Variations in Human Trainability: A Systematic Review.
Petr M; Stastny P; Zajac A; Tufano JJ; Maciejewska-Skrendo A
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29762540
[TBL] [Abstract][Full Text] [Related]
19. IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.
Bochud PY; Bibert S; Kutalik Z; Patin E; Guergnon J; Nalpas B; Goossens N; Kuske L; Müllhaupt B; Gerlach T; Heim MH; Moradpour D; Cerny A; Malinverni R; Regenass S; Dollenmaier G; Hirsch H; Martinetti G; Gorgiewski M; Bourlière M; Poynard T; Theodorou I; Abel L; Pol S; Dufour JF; Negro F; ;
Hepatology; 2012 Feb; 55(2):384-94. PubMed ID: 22180014
[TBL] [Abstract][Full Text] [Related]
20. Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population.
Chen B; Wang Y; Tang W; Chen Y; Liu C; Kang M; Xie J
BMC Med Genomics; 2022 Dec; 15(1):274. PubMed ID: 36587194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
